Drug
Lysozyme
Lysozyme: highest development phase Post-Market, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lysozyme hydrochloride NCT01645800 | Post-Market | COPD |
Latest
No recent events.
Follow Lysozyme on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.